MedPath

GLN-OLMESARTAN HCTZ

GLN-OLMESARTAN HCTZ

Approved
DIN Number

02475707

Drug Class

Human

Market Date

Feb 28, 2020

Company
HC

glenmark pharmaceuticals canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02475707
AIG Number0252502001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
C09DA08 OLMESARTAN MEDOXOMIL AND DIURETICS
Product Specifications
Dosage FormTablet
Route of AdministrationOral
AHFS Classification40:28.20
Health Canada Classification

ACTIVE INGREDIENTS (2)

HYDROCHLOROTHIAZIDEActive
Strength: 12.5 MG
Monograph: HYDROCHLOROTHIAZIDE
OLMESARTAN MEDOXOMILActive
Strength: 20 MG
Monograph: OLMESARTAN MEDOXOMIL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.